The vascular effects of L-arginine in humans: The role of endogenous insulin

Journal of Clinical Investigation

Volumn 99, Issue 3, 1997, Pages 433-438

  Giugliano, Dario ^a   Marfella, Raffaele ^a   Verrazzo, Giovanni ^a   Acampora, Rita ^a   Coppola, Ludovico ^a   Cozzolino, Domenico ^a   D'Onofrio, Felice ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Blood pressure; Blood viscosity; Leg blood flow; Octreotide; Platelet aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ARGININE; CATECHOLAMINE; GLUCAGON; INSULIN; ISOPHANE INSULIN; NITRIC OXIDE; NORADRENALIN; OCTREOTIDE;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CATECHOLAMINE BLOOD LEVEL; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; INSULIN RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; LEG BLOOD FLOW; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION; VASODILATATION;

EID: 0030867403     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119177     Document Type: Article

References (32)

1. Moncada, S., and A. Higgs. 1993. Mechanisms of disease: the L-argininenitric oxide pathway. N. Engl. J. Med. 329:2002-2012.
2. Vallance, P., J. Collier, and A.S. Moncada. 1989. Effects of endothelial-derived nitric oxide on peripheral arteriolar tone in man. Lancet. ii:997-1000.
3. Bode-Böger, S. M., R.H. Böger, A. Creutzig, D. Tsikas, F.-M. Gutzki, K. Alexander, and J.C. Frölich. 1994. L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin. Sci. 87:303-310.
4. Smulders, R.A., C.D.A. Stehouwer, C.G. Olthof, G.J. van Kamp, T. Teerlink, P.M.J.M. de Vries, and A.J.M. Donker. 1994. Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin. Sci. 87:37-43.
5. Mentha, S., D.J. Stewart, S. Hussian, and R.D. Levy. 1994. L-Arginine produces systemic vasodilation and increases nitric oxide excretion in expired gas in humans. Circulation. 90:I-138a. (Abstr.)
6. Marfella, R., G. Verrazzo, L. Coppola, P. Ziccardi, R. Giunta, and D. Giugliano. 1996. Acute hyperglycemia and L-NMMA cause similar vascular effects in man. Diabetes. 45(Suppl. 2):64A.
7. + fluxes in pancreatic B-cells. Am. J. Physiol. 240: E245-E252.
8. Steinberg, H.O., G. Brechtel, A. Johnson, N. Fineberg, and A.D. Baron. 1994. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J. Clin. Invest. 94:1172-1179.
9. Baron, A.D. 1994. Hemodynamic actions of insulin. Am. J. Physiol. 267: E187-E202.
10. Parati, G., R. Casadei, A. Groppelli, M. Di Rienzo, and G. Mancia. 1989. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension (Dallas). 13:647-655.
11. Born, A.V. 1962. Aggregation of blood platelets by adenosindiphosphate and its reversal. Nature (Lond.). 94:927-929.
12. Paolisso, G., D. Giugliano, A.J. Scheen, F. D'Onofrio, and P.J. Lefebvre. 1987. Primary role of glucagon release in the effect of beta-endorphin on glucose homeostasis in normal men. Acta Endocrinol. 115:161-169.
13. Bacchus, R.A., and D.R. London. 1971. The measurement of L-arginine in plasma. Clin. Chim. Acta. 33:479-482.
14. Nakaki, T., K. Hishikawa, H. Suzuki, T. Saruta, and R. Kato. 1990. L-Arginine-induced hypotension. Lancet. ii:696 (Letter).
15. Imaizumi, T., Y. Hirooka, H. Masaki, S. Harada, M. Momohara, T. Tagawa, and A. Takeshita. 1992. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension (Dallas). 20:511-517.
16. Stroes, E.S.G., H.A. Koomans, T.W.A. de Bruin, and T.J. Rahelink. 1995. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet. 346:467-471.
17. Giugliano, D., R. Marfella, G. Varrozzo, R. Acampora, C. Donzella, A. Quatraro, L. Coppola, and F. D'Onofrio. 1995. Abnormal rheologic effects of glyceryl trinitrine in patients with non-insulin-dependent diabetes mellitus and its reversal by antioxidants. Ann. Intern. Med. 123:338-343.
18. Baudouin, S.V., P. Bath, J.F. Martin, R. DuBois, and R. Evans. 1993. L-Arginine infusion has no effects on systemic hemodynamics in normal volunteers, or systemic and pulmonary hemodynamics in patients with elevated pulmonary vascular resistance. Br. J. Clin. Pharmacol. 36:45-49.
19. MacAllister, R.J., A.L. Calver, J. Collier, C.M.B. Edwards, B. Herrebos, S.S. Nussey, and P. Vallance. 1995. Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effects? Clin. Sci. 89: 183-190.
20. Kharitonov, S.A., G. Lubec, B. Lubec, M. Hjelm, and P.J. Barnes. 1995. L-Arginine increases exhaled nitric oxide in normal human subjects. Clin. Sci. 88:135-139.
21. Forstermann, U., E.I. Closs, J.S. Pollock, M. Nakane, P. Schwarz, I. Gath, and H. Kleinert. 1994. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension (Dallas). 23:1121-1131.
22. Arnal, J.-F., T. Münzel, R.C. Venema, N.L. James, C-I. Bay, W.E. Mitch, and D.G. Harrison. 1995. Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. J. Clin. Invest. 95:2565-2572.
23. Panza, J.A., P.R. Casino, D.M. Badar, and A.A. Quyyumi. 1993. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation. 87:1475-1481.
24. Pei, D., C.N. Jones, R. Bhargava, Y.-D.I. Chen, and G.M. Reaven. 1994. Evaluation of octreotide to asses insulin-mediated glucose disposal by the insulin suppression test. Diabetologia. 37:843-845.
25. Marfella, R., G. Verrazzo, R. Acampora, C. La Marca, R. Giunta, C. Lucarelli, G. Paolisso, A. Ceriello, and D. Giugliano. 1995. Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. Am. J. Physiol. 268:E1167-E1173.
26. Trovati, M., P. Massucco, L. Mattiello, F. Cavalot, E. Mularoni, A. Hahn, and G. Anfossi. 1995. Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone. Diabetologia. 38:936-941.
27. Trovati, M., P. Massucco, L. Mattiello, V. Piretto, F. Cavalot, E. Mularoni, and G. Anfossi. 1996. The insulin-induced increase of guanosine-3′,5′-cyclic monophosphate in human platelets is mediated by nitric oxide. Diabetes. 45:768-770.
28. Bogle, R.G., S.B. Coade, S. Moncada, J.D. Pearson, and G.E. Mann. 1991. Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem, Biophys. Res. Commun. 180:929-932.
29. Simmons, W.W., M.Y. Park, J.M. Cunningham, and R.A. Kelly. 1995. Insulin augments cardiac myocyte nitric oxide production by increasing L-arginine transport by the cationic amino acid transporter-1. Circulation. 92(Suppl. 1):I-506a. (Abstr.)
30. Koenig, W., M. Sund, G.D. Lowe, A.J. Lee, K.L. Resch, H. Tunstall-Pedoe, U. Keil, and E. Ernst. 1994. Geographical variations in plasma viscosity and relation to coronary event rates. Lancet. 344:711-714.
31. Laakso, M., S.V. Edelmann, G. Brechtel, and A.D. Baron. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J. Clin. Invest. 85:1844-1852.
32. Laakso, M., S.V. Edelmann, G. Brechtel, and A.D. Baron. 1992. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes. 41:1076-1083.